Sally C. Medley

Array ( [id] => 3646783 [patent_doc_number] => 05605688 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-25 [patent_title] => 'Recombinant dog and horse type I interferons' [patent_app_type] => 1 [patent_app_number] => 8/302391 [patent_app_country] => US [patent_app_date] => 1994-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 74 [patent_figures_cnt] => 74 [patent_no_of_words] => 23801 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/605/05605688.pdf [firstpage_image] =>[orig_patent_app_number] => 302391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3706049 [patent_doc_number] => 05654270 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Use of fibromodulin to prevent or reduce dermal scarring' [patent_app_type] => 1 [patent_app_number] => 8/303238 [patent_app_country] => US [patent_app_date] => 1994-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 29 [patent_no_of_words] => 14550 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654270.pdf [firstpage_image] =>[orig_patent_app_number] => 303238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3963707 [patent_doc_number] => 05885794 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Recombinant production of vertebrate activin receptor polypeptides and identification of receptor DNAs in the activin/TGF-.beta. superfamily' [patent_app_type] => 1 [patent_app_number] => 8/300584 [patent_app_country] => US [patent_app_date] => 1994-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 11561 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/885/05885794.pdf [firstpage_image] =>[orig_patent_app_number] => 300584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3622065 [patent_doc_number] => 05612195 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-18 [patent_title] => 'Recombinant production of a human interferon (IFN)-gamma antagonist cytokine' [patent_app_type] => 1 [patent_app_number] => 8/244557 [patent_app_country] => US [patent_app_date] => 1994-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 14 [patent_no_of_words] => 9327 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/612/05612195.pdf [firstpage_image] =>[orig_patent_app_number] => 244557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3498256 [patent_doc_number] => 05532339 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-02 [patent_title] => 'Fusion protein between human macif and a heterologous pi anchor domain' [patent_app_type] => 1 [patent_app_number] => 8/291339 [patent_app_country] => US [patent_app_date] => 1994-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 14068 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/532/05532339.pdf [firstpage_image] =>[orig_patent_app_number] => 291339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3860322 [patent_doc_number] => 05795779 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-18 [patent_title] => 'Human interferon-.beta. (IFN-.beta.) produced in Chinese hamster ovary (CHO) cells' [patent_app_type] => 1 [patent_app_number] => 8/288796 [patent_app_country] => US [patent_app_date] => 1994-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 24 [patent_no_of_words] => 13700 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/795/05795779.pdf [firstpage_image] =>[orig_patent_app_number] => 288796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3597328 [patent_doc_number] => 05559009 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-24 [patent_title] => 'Voltage-gated potassium channel gene, KV1.7, vectors and host cells comprising the same, and recombinant methods of making potassium channel proteins' [patent_app_type] => 1 [patent_app_number] => 8/288405 [patent_app_country] => US [patent_app_date] => 1994-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 6334 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/559/05559009.pdf [firstpage_image] =>[orig_patent_app_number] => 288405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3498241 [patent_doc_number] => 05532337 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-02 [patent_title] => 'Proteins comprising calmodulin- and actin-binding human caldesmon polypeptide fragments' [patent_app_type] => 1 [patent_app_number] => 8/285440 [patent_app_country] => US [patent_app_date] => 1994-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12336 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/532/05532337.pdf [firstpage_image] =>[orig_patent_app_number] => 285440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3859559 [patent_doc_number] => 05792742 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => 'Fibrin-binding peptide fragments of fibronectin' [patent_app_type] => 1 [patent_app_number] => 8/283857 [patent_app_country] => US [patent_app_date] => 1994-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 57 [patent_no_of_words] => 38278 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792742.pdf [firstpage_image] =>[orig_patent_app_number] => 283857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3620718 [patent_doc_number] => 05614500 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'Compositions containing highly purified factor IX proteins prepared by immunoaffinity chromatography' [patent_app_type] => 1 [patent_app_number] => 8/276505 [patent_app_country] => US [patent_app_date] => 1994-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3865 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614500.pdf [firstpage_image] =>[orig_patent_app_number] => 276505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3610516 [patent_doc_number] => 05510105 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-23 [patent_title] => 'Treatment of autoimmune diseases with IL-2 receptor-specific cytotoxins' [patent_app_type] => 1 [patent_app_number] => 8/275010 [patent_app_country] => US [patent_app_date] => 1994-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3940 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/510/05510105.pdf [firstpage_image] =>[orig_patent_app_number] => 275010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3591415 [patent_doc_number] => 05585475 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-17 [patent_title] => 'Calmodulin-binding peptides and nucleic acids encoding them' [patent_app_type] => 1 [patent_app_number] => 8/268251 [patent_app_country] => US [patent_app_date] => 1994-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6437 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/585/05585475.pdf [firstpage_image] =>[orig_patent_app_number] => 268251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3654468 [patent_doc_number] => 05591427 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-07 [patent_title] => 'Human Interleukin-3(Il-3) variants and their use to promote or antagonize IL-3-mediated processes' [patent_app_type] => 1 [patent_app_number] => 8/211524 [patent_app_country] => US [patent_app_date] => 1994-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4888 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/591/05591427.pdf [firstpage_image] =>[orig_patent_app_number] => 211524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3621667 [patent_doc_number] => 05602010 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'DNA encoding equine-gamma interferon and recombinant production of equine IFN-.gamma. polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/263214 [patent_app_country] => US [patent_app_date] => 1994-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 14557 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/602/05602010.pdf [firstpage_image] =>[orig_patent_app_number] => 263214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3811889 [patent_doc_number] => 05710027 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-20 [patent_title] => 'Process and vector for expressing alpha-interferon in E. coli' [patent_app_type] => 1 [patent_app_number] => 8/249671 [patent_app_country] => US [patent_app_date] => 1994-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 7976 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/710/05710027.pdf [firstpage_image] =>[orig_patent_app_number] => 249671 [rel_patent_id] =>[rel_patent_doc_number] =>)